Login to Pancreatic Cancer UK

We comment on a new study that shows cancer survival in the UK is lower compared to other high-income countries

Posted by: Policy and campaigning 12 September 2019

A new study, reported in the BBC suggests that cancer survival in the UK is improving but it is lagging behind other high-income countries. The study (published in Lancet Oncology on September 11th) looked at 3.9 million cancer cases in Australia, Canada, Demark, Ireland, New Zealand, Norway and the UK over 20 years.

Anna Jewell, Director of Services, Influencing and Research at Pancreatic Cancer UK said:

“It is incredibly disappointing to see the UK lagging so far behind other countries and it is appalling that survival for pancreatic cancer, the nation’s deadliest common cancer, has remained so low, for so long. 1 in 4 people die within a month of diagnosis and this needs to change. Early diagnosis is key to improving survival but currently there is no simple test for the disease and treatment options are extremely limited. But patients can’t afford to wait for these scientific breakthroughs alone and there is much we can learn from other countries and put into practice. We can take action to help those diagnosed now by ensuring people start treatment within 20 days and that best practice guidelines are followed.”